Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3 - PubMed (original) (raw)

Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3

J D Potts et al. Proc Natl Acad Sci U S A. 1991.

Abstract

During early cardiac development, the progenitor cells of the heart valves and membranous septa undergo an epithelial-mesenchymal transformation. Previous studies have shown that this transformation depends on the activity of a transforming growth factor beta (TGF beta) molecule produced by the heart. In the present study, we have used modified antisense oligodeoxynucleotides generated to nonconserved regions of TGF beta 1, -2, -3, and -4 to examine the possible roles of these members in this transformation. A phosphoramidate-modified oligonucleotide complementary to TGF beta 3 mRNA was capable of inhibiting normal epithelial-mesenchymal transformation by 80%. Unmodified oligonucleotides to TGF beta 3, modified oligonucleotides to TGF beta 1, -2, and -4, and two modified control oligonucleotides were unable to inhibit the transformation. These data demonstrate that a specific member of the TGF beta family, TGF beta 3, is essential for the epithelial-mesenchymal cell transformation.

PubMed Disclaimer

References

    1. Am J Anat. 1977 Jan;148(1):85-119 - PubMed
    1. Cell Regul. 1990 Feb;1(3):301-13 - PubMed
    1. Dev Biol. 1983 Jan;95(1):108-14 - PubMed
    1. Dev Biol. 1983 Oct;99(2):395-407 - PubMed
    1. Dev Biol. 1985 Dec;112(2):414-26 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources